![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0138.jpg)
Copyright 2016 American Medical Association. All rights reserved.
17
. Yamada M, Hatta N, Sogo K, Komura K,
Hamaguchi Y, Takehara K. Management of
squamous cell carcinoma in a patient with
recessive-type epidermolysis bullosa dystrophica.
Dermatol Surg . 2004;30(11):1424-1429 .18
. Perez-Naranjo L, Herrera-Saval A, Garcia-Bravo
B, Perez-Bernal AM, Camacho F. Sentinel lymph
node biopsy in recessive dystrophic epidermolysis
bullosa and squamous cell carcinoma
. Arch Dermatol . 2005;141(1):110-111 .19
. Navarrete-Dechent C, Veness MJ,
Droppelmann N, Uribe P. High-risk cutaneous
squamous cell carcinoma and the emerging role of
sentinel lymph node biopsy: A literature review.
J Am Acad Dermatol . 2015;73(1):127-137 .20
. Renzi C, Caggiati A, Mannooranparampil TJ,
et al. Sentinel lymph node biopsy for high risk
cutaneous squamous cell carcinoma: case series
and review of the literature
. Eur J Surg Oncol . 2007; 33(3):364-369 .21
. Takahashi A, Imafuku S, Nakayama J, Nakaura J,
Ito K, Shibayama Y. Sentinel node biopsy for
high-risk cutaneous squamous cell carcinoma
. Eur J Surg Oncol . 2014;40(10):1256-1262 .22
. Fukushima S, Masuguchi S, Igata T, et al.
Evaluation of sentinel node biopsy for cutaneous
squamous cell carcinoma
. J Dermatol . 2014;41(6): 539-541 .23
. Stoffels I, Boy C, Pöppel T, et al. Association
between sentinel lymph node excision with or
without preoperative SPECT/CT and metastatic
node detection and disease-free survival in
melanoma
. JAMA . 2012;308(10):1007-1014 .24
. Spanknebel K, Coit DG, Bieligk SC, Gonen M,
Rosai J, Klimstra DS. Characterization of
micrometastatic disease in melanoma sentinel
lymph nodes by enhanced pathology:
recommendations for standardizing pathologic
analysis
. Am J Surg Pathol . 2005;29(3):305-317 .25
. Yu LL, Flotte TJ, Tanabe KK, et al. Detection of
microscopic melanoma metastases in sentinel
lymph nodes.
Cancer . 1999;86(4):617-627 .26
. Gershenwald JE, Colome MI, Lee JE, et al.
Patterns of recurrence following a negative sentinel
lymph node biopsy in 243 patients with stage I or II
melanoma
. J Clin Oncol . 1998;16(6):2253-2260 .27
. Li LX, Scolyer RA, Ka VS, et al. Pathologic
review of negative sentinel lymph nodes in
melanoma patients with regional recurrence:
a clinicopathologic study of 1152 patients
undergoing sentinel lymph node biopsy
. Am J Surg Pathol . 2003;27(9):1197-1202 .28
. Lobo AZ, Tanabe KK, Luo S, et al. The
distribution of microscopic melanoma metastases
in sentinel lymph nodes: implications for pathology
protocols.
Am J Surg Pathol . 2012;36(12):1841-1848 .29
. Cochran AJ, Wen DR, Herschman HR. Occult
melanoma in lymph nodes detected by antiserum
to S-100 protein.
Int J Cancer . 1984;34(2):159-163 .30
. Karimipour DJ, Lowe L, Su L, et al. Standard
immunostains for melanoma in sentinel lymph
node specimens: which ones are most useful
? J Am Acad Dermatol . 2004;50(5):759-764 .31
. Ahmed MM, Moore BA, Schmalbach CE. Utility
of head and neck cutaneous squamous cell
carcinoma sentinel node biopsy: a systematic
review
. Otolaryngol Head Neck Surg . 2014;150(2): 180-187 .32
. Gore SM, Shaw D, Martin RC, et al. Prospective
study of sentinel node biopsy for high-risk
cutaneous squamous cell carcinoma of the head
and neck
. Head Neck . 2016;38(suppl 1):E884-E889 .33
. Thompson AK, Kelley BF, Prokop LJ, Murad
MH, Baum CL. Risk Factors for Cutaneous
Squamous Cell Carcinoma Recurrence, Metastasis,
and Disease-Specific Death: A Systematic Review
and Meta-analysis.
JAMA Dermatol . 2016;152(4): 419-428 .34
. Schmults CD, Karia PS, Carter JB, Han J,
Qureshi AA. Factors predictive of recurrence and
death from cutaneous squamous cell carcinoma:
a 10-year, single-institution cohort study
. JAMA Dermatol . 2013;149(5):541-547 .Research
Original Investigation
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma on the Head and Neck
JAMA Otolaryngology–Head & Neck Surgery
Published online July 20, 2016
(Reprinted)
jamaotolaryngology.com118